Evidence map›Paper›PMID 40983935›Full record

ArticleRadiation oncology (London, England)2025

SSTR PET/CT for skull base low-grade meningioma: a critical tool for accurate gross tumor volume delineation in radiotherapy?

Frederik Fuchs, Sebastian N Marschner, Jan Hofmaier, Maya Rottler, Indra Hadi, Sebastian H Maier, Tobias Greve, Adrien Holzgreve, Nathalie L Albert, Raphael Bodensohn and 3 more

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Frederik Fuchs *Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany. Frederik.fuchs@med.uni-muenchen.de.
Sebastian N Marschner *Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Jan HofmaierDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Maya RottlerDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Indra HadiDepartment of Radiation Oncology, Hospital Lüneburg, Lüneburg, Germany.
Sebastian H MaierDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Tobias GreveDepartment of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Nathalie L AlbertGerman Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Raphael BodensohnDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Claus BelkaDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Maximilian NiyaziDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Franziska WalterDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrecise delineation of gross tumor volume (GTV) is fundamental for effective radiation therapy in low-grade skull base meningiomas. Magnetic resonance imaging (MRI) serves as the primary imaging tool but may not fully represent tumor extent. This study investigates the additional value of incorporating Somatostatin receptor (SSTR)-directed PET/CT in radiation therapy planning.

methodsA retrospective analysis was conducted with four experienced radiation oncologists contouring GTVs for skull base meningiomas using MRI alone (GTV_MRI), PET/CT alone (GTV_PET/CT), and both modalities combined (GTV_ALL). Consensus ground truth volumes were generated for each modality through a STAPLE algorithm. Agreement between modalities, excluding observer variability, was assessed using statistical metrics including Dice Similarity Coefficient (DSC), Jaccard Index (JCI), Hausdorff distance (HD95), Geographical Miss Index (GMI), sensitivity, and kappa statistics.

resultsThe study included 25 patients (15 females, 10 males; median age 56 years (range: 23-74 years), with 96% achieving local control post-radiotherapy over a median follow-up of 64 months (range: 28-135 months). Substantial interobserver agreement was observed, with median kappa values of 0.74 for GTV_MRI, 0.68 for GTV_PET/CT, and 0.77 for GTV_ALL. Median consensus volumes were 6.65 cc (MRI

conclusionCombining MRI and PET/CT improves GTV delineation in low-grade skull base meningiomas, as PET/CT can reveal regions missed by MRI, which may slightly underestimate tumor size. This multimodal imaging approach enhances consensus and supports its role in radiotherapy planning. Standardized protocols and technical integration remain key future goals.

Indexed as

Meningeal NeoplasmsMeningiomaPositron Emission Tomography Computed TomographyRadiotherapy Planning, Computer-AssistedReceptors, SomatostatinSkull Base NeoplasmsAdultAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesTumor BurdenYoung AdultReceptors, SomatostatinContouringMeningiomaMRIPET/CTRadiotherapySkull base

Identifiers

PMID40983935
PMCPMC12455788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.